Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Vera

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Scientific Reports|December 2, 2021
Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin's lymphomaPierre Pinochet, Edgar Texte, Aspasia Stamatoullas-Bastard, et al.
Annals of Nuclear Medicine|January 21, 2022
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumabFlorian Eude, Florian Guisier, Mathieu Salaün, et al.
Nuclear Medicine Communications|March 13, 2013
Reproducibility of the adaptive thresholding calibration procedure for the delineation of 18F-FDG-PET-positive lesionsKaya Doyeux, Sébastien Vauclin, Sébastien Hapdey, et al.
EJNMMI Radiopharmacy and Chemistry|May 19, 2026
GMP-compliant automated synthesis and quality control of [<sup>177</sup>Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancerAmélie Coussirou, Mélodie Six, Agathe Edet-Sanson, et al.
Plos One|July 4, 2017
In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopyFlorian Guisier, Pierre Bohn, Maxime Patout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2013
Does enhanced CT influence the biological GTV measurement on FDG-PET images?Pierre Vera, Romain Modzelewski, Sebastien Hapdey, et al.
EJNMMI Research|November 23, 2023
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumorsArnaud Dieudonné, Stéphanie Becker, Miguel Soares, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 26, 2015
18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncologyKoutoua J Anouan, Benoît Lelandais, Agathe Edet-Sanson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2018
Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on <sup>18</sup>F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphomaPierre Decazes, Stéphanie Becker, Mathieu Nessim Toledano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Scientific Reports|December 2, 2021
Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin's lymphomaPierre Pinochet, Edgar Texte, Aspasia Stamatoullas-Bastard, et al.
Annals of Nuclear Medicine|January 21, 2022
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumabFlorian Eude, Florian Guisier, Mathieu Salaün, et al.
Nuclear Medicine Communications|March 13, 2013
Reproducibility of the adaptive thresholding calibration procedure for the delineation of 18F-FDG-PET-positive lesionsKaya Doyeux, Sébastien Vauclin, Sébastien Hapdey, et al.
EJNMMI Radiopharmacy and Chemistry|May 19, 2026
GMP-compliant automated synthesis and quality control of [<sup>177</sup>Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancerAmélie Coussirou, Mélodie Six, Agathe Edet-Sanson, et al.
Plos One|July 4, 2017
In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopyFlorian Guisier, Pierre Bohn, Maxime Patout, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2013
Does enhanced CT influence the biological GTV measurement on FDG-PET images?Pierre Vera, Romain Modzelewski, Sebastien Hapdey, et al.
EJNMMI Research|November 23, 2023
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumorsArnaud Dieudonné, Stéphanie Becker, Miguel Soares, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 26, 2015
18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncologyKoutoua J Anouan, Benoît Lelandais, Agathe Edet-Sanson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2018
Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on <sup>18</sup>F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphomaPierre Decazes, Stéphanie Becker, Mathieu Nessim Toledano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Pageof 15